Rhoen Klinikum AG (ETR:RHK)‘s stock had its “sell” rating reaffirmed by analysts at DZ Bank AG in a research report issued to clients and investors on Tuesday.

A number of other brokerages have also recently commented on RHK. Deutsche Bank AG set a €21.00 ($25.00) price target on Rhoen Klinikum AG and gave the company a “neutral” rating in a research note on Wednesday, July 26th. Independent Research GmbH set a €28.00 ($33.33) price target on Rhoen Klinikum AG and gave the company a “neutral” rating in a research note on Monday, August 14th. Jefferies Group LLC set a €17.60 ($20.95) price target on Rhoen Klinikum AG and gave the company a “sell” rating in a research note on Thursday, August 3rd. Commerzbank Ag set a €25.00 ($29.76) price target on Rhoen Klinikum AG and gave the company a “neutral” rating in a research note on Tuesday, July 25th. Finally, Credit Suisse Group set a €24.40 ($29.05) price target on Rhoen Klinikum AG and gave the company a “sell” rating in a research note on Friday, August 4th. Three research analysts have rated the stock with a sell rating and six have given a hold rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of €24.06 ($28.65).

Shares of Rhoen Klinikum AG (ETR RHK) opened at 27.715 on Tuesday. The firm has a 50-day moving average price of €26.46 and a 200 day moving average price of €25.97. Rhoen Klinikum AG has a 12 month low of €22.91 and a 12 month high of €27.95. The firm has a market capitalization of €1.86 billion and a price-to-earnings ratio of 433.047.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/08/31/rhoen-klinikum-ag-rhk-rating-reiterated-by-dz-bank-ag.html.

About Rhoen Klinikum AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum AG (ETR:RHK)

Receive News & Stock Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related stocks with our FREE daily email newsletter.